Clinical Trials Logo

Fibromyalgia Syndrome clinical trials

View clinical trials related to Fibromyalgia Syndrome.

Filter by:

NCT ID: NCT04517929 Completed - Clinical trials for Fibromyalgia Syndrome

Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome

Start date: October 20, 2020
Phase: N/A
Study type: Interventional

The hypothesis of the study is that group therapy in fibromyalgia patients can provide significant improvement in pain, fatigue, anxiety and depression levels and emotional expressions.

NCT ID: NCT04437524 Completed - Clinical trials for Fibromyalgia Syndrome

Comparison of the Effects of Balance-proprioception and Aerobic Exercises on Functional Status and Strength Parameters in Patients With Fibromyalgia.

FMS
Start date: August 24, 2020
Phase: N/A
Study type: Interventional

In this study, it was aimed to examine the effects of aerobic exercise and balance-proprioception exercises on pain, functionality and strength parameters of fibromyalgia patients and to compare the two exercise types.

NCT ID: NCT04426864 Completed - Clinical trials for Fibromyalgia Syndrome

Efficacy of Different Types of Exercises in Women With Fibromyalgia Syndrome.

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Objective: To demonstrate the most effective exercise intervention for women with fibromyalgia syndrome on the pain, quality of life, depression, and body composition through a comparative study of three types of exercise intervention: supervised aerobic plus stretching, supervised resistance plus stretching, and home-based stretching.

NCT ID: NCT04170387 Not yet recruiting - Fibromyalgia Clinical Trials

Can a Relaxometer Improve Cognitive Impairment of Fibromyalgia Patients

Fibrorilax
Start date: December 15, 2019
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the differences in cognitive performance and quality of life, after a cycle of treatment with the relaxometer, between a group of patients affected by fibromyalgia and a control group.

NCT ID: NCT03844412 Completed - Clinical trials for Irritable Bowel Syndrome

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Start date: November 4, 2019
Phase: Phase 2
Study type: Interventional

Vestibulodynia (VBD) is a complex chronic vulvar pain condition that impairs the psychological, physical, and sexual health of 1 in 6 reproductive aged women in the United States. Here, the investigators plan to conduct a randomized, double-blinded, placebo-controlled clinical trial to 1) compare the efficacy of peripheral (lidocaine/estradiol cream), centrally-targeted (nortriptyline), and combined treatments in alleviating pain and improving patient-reported outcomes and 2) determine cytokine and microRNA biomarkers that predict treatment response in women with distinct VBD subtypes. Positive findings from this study will readily translate to improved patient care, permitting the millions of women with VBD, their partners, and their clinicians to make more informed decisions about pain management.

NCT ID: NCT02881411 Completed - Clinical trials for Fibromyalgia Syndrome

Self Soft Tissue Therapy for Fibromyalgia Syndrome

Start date: July 2016
Phase: N/A
Study type: Interventional

The main aims of this preliminary research are to determine if combined self-soft tissue therapy (SSTT) alongside an established 6 week FMS Coping Skills Programme (FCSP) is a feasible and acceptable treatment approach for FMS. All participants on the six week FCSP will be randomly allocated to a control (FMS Coping Skills Programme) or intervention group (FMS Coping Skills Programme plus SSTT). All participants will be assessed for outcome measurements at the start of the feasibility study, at six weeks and three months after completion. This feasibility study hypothesis is that the SST approach will be acceptable to FMS patients and that the combined 6 week FCSP (hands off) and SSTT (hands on) will be beneficial. This feasibility study will inform a larger randomized controlled trial (RCT) on this combined treatment approach to FMS.

NCT ID: NCT02800720 Completed - Clinical trials for Fibromyalgia Syndrome

Meditation Awareness Training for the Treatment of Fibromyalgia Syndrome

Start date: November 2012
Phase: N/A
Study type: Interventional

A Randomised Controlled Trial to evaluate the effectiveness of a Second-Generation Mindfulness-Based Intervention known as Meditation Awareness Training (MAT) for treating fibromyalgia syndrome.

NCT ID: NCT02561416 Completed - Clinical trials for Fibromyalgia Syndrome

Cost-utility and Biological Underpinnings of MBSR in Fibromyalgia Syndrome

EUDAIMON
Start date: January 1, 2016
Phase: Phase 3
Study type: Interventional

Purpose: Fibromyalgia syndrome (FMS) is a disabling condition mainly characterized by chronic widespread pain, disturbed sleep, fatigue, and distress. The estimated overall prevalence of FMS in Europe is 2.9% and it incurs in high personal, social and healthcare costs. Available treatments in FMS are not curative and there is some evidence of positive effects of mindfulness-based stress reduction (MBSR) in patients with chronic pain and FMS. Nevertheless, although promising, the positive findings obtained in previous studies implementing mindfulness-based interventions in patients with FMS have to be interpreted with caution due to important methodological limitations (e.g. absence of randomization, high attrition rates, or small sample sizes). Therefore, further research in larger studies using more adequate methodologies is warranted. Furthermore, little is known about putative neurobiological processes underpinning the effects of mindfulness training in patients with chronic pain. Aims: The aim of this randomized, controlled trial (RCT) is two-fold: firstly, to assess the effectiveness and cost-utility of MBSR added to treatment as usual (TAU); and secondly, to evaluate the effects of the compared interventions on neurobiological parameters. Specifically, MBSR will be compared to an active control which was previously reported as a cost-effective intervention (TAU + FibroQol psycho-educational program; Luciano et al., 2013) and also vs. TAU alone (in a 12-month follow-up RCT). Brain structure and function of pain-relevant areas and levels of inflammation markers (cytokines) will be assessed pre-post interventions in half of the study participants. Methods: Design: RCT with three arms: 1. TAU + MBSR, 2. TAU + FibroQoL and 3. TAU. Sample: 180 adults with FMS according to the ACR 1990 criteria (N=60 for each study arm) will be recruited from from the Parc Sanitari Sant Joan de Déu Rheumatology Service, Sant Boi de Llobregat, Spain. Half of the participants will be randomly selected to participate in the neurobiological pre-post evaluation (N= 30 each group). All patients will be assessed at baseline, post-intervention and 12-month follow-up for clinical variables, prep-post intervention for biomarkers study, and baseline and 12-month follow-up for cost-related variables.

NCT ID: NCT02548065 Completed - Clinical trials for Fibromyalgia Syndrome

Efficacy and Tolerability of Balneotherapy With Mineral Water Named" Debole of Vetriolo" in Fibromyalgia Syndrome

VET
Start date: April 1, 2015
Phase: N/A
Study type: Interventional

The present randomized, controlled double blind trial aims to evaluate the efficacy and tolerability of balneotherapy with mineral water named "Debole of Vetriolo" in 100 patients with primary Fibromyalgia Syndrome (FS).

NCT ID: NCT02343237 Completed - Clinical trials for Fibromyalgia Syndrome

Osteopathic Medicine in Fibromyalgia Syndrome

FIBROPATHIC
Start date: December 2, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the analgesic effects of a 6 weeks osteopathic treatment on patients with fibromyalgia.